Found this on another silver list. May be of interest.
----- Original Message ----- From: <colloidalsil...@onelist.com> To: <colloidalsil...@onelist.com> Sent: Wednesday, November 17, 1999 2:17 AM Subject: [colloidalsilver] Digest Number 13 ----------------------------------------------------- > > There is 1 message in this issue. > > Topics in today's digest: > > 1. Colloidal Silver Newsletter > From: Steve Barwick <barw...@telis.org> > > > ____________________________________________________________________________ ___ > ____________________________________________________________________________ ___ > > Message: 1 > Date: Tue, 16 Nov 1999 12:17:19 -0800 > From: Steve Barwick <barw...@telis.org> > Subject: Colloidal Silver Newsletter > > Using Colloidal Silver Against Bloodborne Infections: > New Protocol Against AIDS Shows Promise > > [Editor's Note: I have made reference in several past articles to a new > protocol for using colloidal silver to treat AIDS. This protocol was > originally developed by Dr. Philip Burris, Ph.D., and was successfully > tested on animals with HIV-like disease. Later, it was tested by Dr. > Cesar Garcia Ramirez, MD on several dying AIDS patients, with what > appear to be phenomenally successful results. A brief article > containing a background history of these studies was written by a Dr. > Charles D. Beal, M.D., and was subsequently posted to an internet site > on June 6, 1998 at the following address: > http://www.pathogen.com/Silver_Ion_Therapy.html > > Since I first referenced Dr. Beal's article and gave the web site > address so others could access it, the article has mysteriously been > pulled from the web site and is no longer available. Fortunately, I had > downloaded the article before it was removed. Below, I have reprinted > it in its entirety, solely for non-commercial, educational purposes. It > is my hope that the research described in this article is continuing, > and will be made public as further data becomes available. If anyone > has additional information on this research, or on any successful > medically documented protocol for using colloidal silver against AIDS or > other bloodborne infections, please email me at the email address posted > at the bottom of this article.] > > ---------------------------------------------------------------- > > Silver Ion Therapy for HIV/AIDS and Septicemia > > by Dr. Charles D. Beal, M.D. > > Silver in various forms has long been known to be microbicidal. In > recent years it has been used to sterilize waste water, often in > combination with chlorine as a means to reduce the dosage of chlorine > needed. Silver iodide and other silver salts have been used medically > as antiseptics for decades. In l978, Dr. Robert O. Becker, an > orthopedic surgeon treated a series of infected, open long bone > fractures, resistant to all available antibiotics. He used silver ions > produced by a low intensity direct current (LIDC) applied to silver > coated nylon meshes placed on the open wounds. > > The report showed excellent results, but did not generate much interest > in the medical community, which continued to rely on new antibiotics as > they became available, but still with not infrequent failures. > > In 1989, while attending the international AIDS Conference in San > Francisco, Philip Burris, Ph.D., wondered if silver ions could be used > to kill the HIV virus in humans. He was able to have done in vitro > studies showing that the LIDC technology could prevent the transmission > of the HIV virus from infected to non-infected lymphocytes without > damaging the lymphocytes. Other studies showed many bacteria to be > quite sensitive to silver ions, with human cells being much less > sensitive. Waste water studies of viruses occurring in sewage found the > hepatitis A virus to be the most resistant to silver ions, the polio > virus less resistant, and the rotovirus the most sensitive. The > hepatitis virus, of course, is known to be quite resistant to > antiseptics, heat and drying. The method appears useful for the > eradication of Legionella pneumophilia from cooling systems. > > Rationale for Treatment of HIV With Silver Ions > > Silver ions are produced in enormous quantities when an electric current > is passed through silver metal in saline or other conducting solution, > including blood. The amount of current needed is much lower than the > current needed to affect the heart muscle. Silver ions are positively > charged while viruses and bacteria have a weak negative charge. Thus, > there is a mutual attraction between the ions and the organisms, the > latter being inactivated by the ions. It seems likely that the silver > ions also attach to red blood cells and proteins in the blood, as well > as combining with chloride ions. Nevertheless, the enormous quantity of > silver ions produced appear adequate to destroy the viral particles. > The half-life of the ions in the blood is calculated to be 7.8 seconds, > giving them time to react with many virons, particularly if the > electrode is placed in a large blood vessel, such as the superior vena > cava, which empties directly into the heart with blood from many > different veins. The blood entering the heart then is pumped > immediately to the lungs where the ions should still be active. It is > not known, however, whether silver ions delivered via the blood stream > will be found to be useful to treat pulmonary infections. The blood > returning to the heart after oxygenation then is distributed to the > remainder of the body. An electrode placed in an artery should be able > to deliver the ions directly and rapidly to the target organ. How > practical or effective such treatment would be is not known. > > Animal Studies > > Both cats and certain primates can be infected with a fatal disease > caused by retroviruses similar to HIV. The feline immunodeficiency > virus (FIV) appears to be transmitted to other cats through the saliva, > that is through biting. FIV is not known to be infectious to humans. > Dr. Burris was able to obtain one very ill FIV infected cat from a > neighbor, but could not convince any veterinarian in the area to treat > the cat with silver ions. Eventually he found a research veterinarian > practicing in Tijuana, Baja California, Mexico, who anesthetized the > cat, placed a silicone rubber catheter containing a silver wire > protruding from its end into the superior vena cava via a jugular vein. > A cathode was attached to the skin of the chest. The microamp power > indicated above was applied for 22 minutes by means of a small power > supply, followed by the nanoamp power for 90 minutes. It was assumed > that the cat would soon die of its disease. Thus the primary purpose of > this treatment was to determine silver levels in the blood. It was > found that the natural level was increased only briefly by about 10%. > All animals maintain trace amount of silver in the body. Of great > interest, however, is that by the second post-treatment day the cat > began eating well, and within four weeks the many sores on its back and > ears had healed. The cat was treated in March, l996, and at the present > appears perfectly healthy. It is not known whether some infectious > agents remain in the cat's body. Since that apparently successful > effort, attempts have been made to obtain the FIV infected cats for > treatment, but so far without success. We have been informed, however, > that in recent years neither the FDA nor the National Institutes of > Health (NIH) have been requiring animal studies prior to evaluating > anti-HIV drugs in humans. > > Human Studies > > Cesar Garcia Ramirez, MD, practicing in Tijuana, became aware of the FIV > treatment, and felt that it would be a compassionate act to at least try > the therapy on some of his dying AIDS patients. He obtained permission > from the Baja California Division of Public Health, as well as agreement > for the treatment protocol from a group of physicians serving as the > institutional Review Board (Human Studies Committee). Volunteer > patients were fully informed and signed consent forms. Initially, three > very ill patients were chosen. Silver electrodes in silicon rubber > catheters were placed in arm veins and passed up as far as the vena > cava, or near to it. Each patient was treated for 12 minutes at 2.5 > microamps, then for 72 hours at 125 microamps except that one patient > was treated for only 48 hours. All three patients felt better by the > second day, and considerably better by Day 5. Viral loads dropped > precipitously, almost to zero in one patient and much lower than the > initial count in the other two. Laboratory and clinical results are > attached. [Editor's note: the results were not accessible on the web > site.] The next three months were spent in equipment improvement, > seeking to be able to reduce viral loads rapidly to zero in all > patients, and to be able to maintain the zero level for weeks or months > if need be until the badly damaged immune system has had time to recover > and be able to itself to combat the infection. The virus is present not > only in the blood stream, but also in lymph nodes and other organs of > the body. > > Currently in the Tijuana study catheters are implanted; in the > subclavian vein (behind the clavicle) and extend to the right auricle of > heart, with the electrode protruding from the end of the catheter. > Since the electrodes in their present form oxidize and stop producing > ions in about 5 days, the present system allows the silver electrode to > be removed and replaced while the catheter remains in place. Using this > method viral levels have been maintained at zero, or nearly so for six > weeks in one patient. Her CD4 count is now beginning to rise, as is the > total lymphocyte count. Most importantly, she feels very much better > than prior to treatment. She also was infected with herpes, hepatitis > C, toxoplasmosis of the brain, and cytomegalovirus (CMV) affecting one > eye. It thus is very surprising that the patient has improved so much. > Whether any of these secondary opportunistic infections have in reality > been successfully treated can be determined only after prolonged > follow-up. Many more patients will need to be treated and followed for > these often fatal complications. > > In addition to the work described above, 18 AIDS patients, all seriously > ill are now under treatment. The therapy is being done on a > compassionate basis, responding to very strong pressure from the local > AIDS community, their families and friends. Unfortunately, in none of > these 18 is adequate laboratory work being performed, simply because the > cost of the rather extensive studies required to document the value of > silver ion therapy is too great. Virtually all of these patients are > destitute. It is very gratifying, nevertheless, that all of them now > are feeling very much better, and some quite well. It is little wonder > that there is such pressure for treatment. > > Side Effects of Silver Ion Therapy > > Until now no side effects attributable to this therapy have been > observed. It should be remembered that the present most effective oral > therapy available - protease inhibitors used in combination with other > drugs is quite toxic, producing many side effects, enough so that some > patients are unable to tolerate the therapy. One patient that was > treated with silver ions for only 48 hours had a serious flare-up of his > herpes infection soon after the treatment was stopped. On the other > hand, the woman described above who was treated for 6 weeks, experienced > a disappearance of her herpes lesion. At present it is impossible to > say whether the silver ion therapy was the cause of the effect in either > case. > > Silver Metal Toxicity > > Silver appears to be a relatively non-toxic trace metal for mammals. It > is largely metabolized and excreted by the liver into the bile and > eliminated from the body. In the past the excessive and long term use > of silver compound nose and eye drops in some people were found to > produce a grayish discoloration of the skin, termed "argyria." Even the > large amount of silver required to produce this staining appeared to > cause no other problems. Some silver compounds, such as silver nitrate > are highly caustic. It has been observed that ingestion of 10 grams of > this substance is fatal to human adults, but the amount of colloidal > silver entering the body using the above protocol is measured in > micrograms. It is not certain that some months of treatment will not > produce evidence of toxicity, but it is considered a very good sign that > none has been observed so far. > > Anticipated Further Studies > > As of the present only 4 patients have been treated and followed with > adequate laboratory studies. The ideal design of the equipment and its > use in the body continues to need exploration. How long initial therapy > needs to be continued remains to be determined, and whether periodic > pretreatment will be required can only be determined by long term > follow-up of the patients. Whether silver ion therapy will work best in > combination with other modes of treatment must be explored. It is > believed that for the initial Phase 1 studies conducted in Tijuana a > total of 50 patients need to be treated and carefully followed, > collecting enough laboratory and clinical data to present to the US FDA, > as well as regulatory bodies of other countries, in order to gain > permission to continue the trials in the USA and elsewhere. Laboratory > research needs to accompany the clinical work. It seems likely that > there will be many other applications for silver ion therapy, such as > the treatment of septicemias (bacteremias) and other infections. > Septicemia is a very common cause of death in seriously ill and in some > healthy patients who contract antibiotic resistant ("killer") > streptococci, as well as other highly pathogenic bloodborne organisms. > Septicemia being bloodborne, should be immediately and forcefully > reacted upon by the silver ions. For antibiotic resistant septicemias > there presently are no satisfactory therapeutic options, though many > millions of dollars have been spent in the search. > > Some of the many agents responsible for respiratory infections may > respond to the therapy. Preliminary laboratory work can help define > which infections are more likely to respond. It is known that some > leukemias and certain other cancers are related to viral infections. > Some patients suffering from chronic fatigue and similar syndromes may > have indolent viral infections. All of these possibilities need to be > explored as to whether or not they will respond to silver ions. Agents > of tropical diseases such as malaria, typhoid, Chagas, and leishmaniasis > should undergo preliminary laboratory evaluation prior to human trials. > Lassa, Ebola and Hanta Viruses, often rapidly fatal, might respond to > quite short term, easily administered therapy. Thus almost certainly > the most immediate and urgent use of silver ions will be found in the > treatment of HIV/AIDS and septicemia. Still, many other possibilities > eventually should be explored. > > --------------------------------------- > > COPYRIGHT 1999. LIFE & HEALTH RESEARCH GROUP > NO REPRODUCTION WITHOUT THE EXPRESS > WRITTEN PERMISSION OF THE PUBLISHER > > Note: Information printed in this newsletter is received from sources > deemed reliable, but no guarantee, express or implied, can be made > regarding the accuracy of same. Therefore readers are encouraged to > verify for themselves and to their own satisfaction the accuracy of all > reports, recommendations, conclusions, comments, and opinions. > Additionally, the contents of this newsletter are strictly for > information purposes only, and should not in any way be construed as > providing or attempting to provide medical advice. You should always > consult with a competent and fully- informed medical professional before > making any personal or family health-care decisions. > > > CONTACT INFORMATION: > > Silver Bullet Enterprises > "World's Finest Home Colloidal Silver Generators" > 25277 W. Main St., Dept. INT > Lenwood, CA 92311 > > Voice: (760) 253-2988 > Fax: (760) 253-1158 > Email: barw...@telis.org > > > ____________________________________________________________________________ ___ > ____________________________________________________________________________ ___ > -- The silver-list is a moderated forum for discussion of colloidal silver. To join or quit silver-list or silver-digest send an e-mail message to: silver-list-requ...@eskimo.com -or- silver-digest-requ...@eskimo.com with the word subscribe or unsubscribe in the SUBJECT line. To post, address your message to: silver-list@eskimo.com Silver-list archive: http://escribe.com/health/thesilverlist/index.html List maintainer: Mike Devour <mdev...@id.net>
